Telemonitoring System Study in Participants With Type 2 Diabetes Mellitus (MK-0000-347)

A Randomized Clinical Trial on Home Telemonitoring for the Management of Metabolic and Cardiovascular Risk in Individuals With Type 2 Diabetes

The primary goal is to evaluate whether a home telehealth system that enables the participant to monitor their body weight, blood glucose values and blood pressure values, associated with remote educational support and feedback to the general practitioner, can improve metabolic control and overall cardiovascular risk in individuals with type 2 diabetes mellitus (T2DM), as compared to usual practice.

Inclusion Criteria:

• has type 2 diabetes
• treated with oral agents in monotherapy or combined therapy ± basal insulin
• previously educated to self-monitoring blood glucose (SMBG) use

Exclusion Criteria:

• has type 2 diabetes non-pharmacologically treated
• has type 2 diabetes treated with multiple daily injections of insulin
• is unable to use the telemedicine system
• pregnancy
• has major cardiovascular, cerebrovascular, or peripheral vascular event in the last 6 months
• has any disease or condition, including alcohol or drugs abuse, that may interfere with study completion